Assist. Prof. Dr Dalia Zaafar, Cairo University, Egypt
Dr. Dalia Zaafar is an Assistant Professor at Modern University for Technology and Information (MTI) in Egypt, specializing in pharmacology, toxicology, and clinical pharmacy. With a Ph.D. from Cairo University, she has led impactful research on cardiovascular pharmacology and oncology. 🌍 Her work includes clinical studies, focusing on metformin and sorafenib, contributing to drug safety. Dr. Zaafar is passionate about mentoring young researchers, especially women in academia, and has presented at international conferences. 🎓 She holds certifications in clinical practice and data analysis, enhancing her role as an expert in her field. 📚
Publication Profile
Google Scholar
Orcid
Scopus
Educational Background 🎓
Dr. Dalia Zaafar holds a Ph.D. in Pharmacology and Toxicology from Cairo University (2019), with a focus on clinical studies and cardiovascular pharmacology. Her dissertation explored the efficacy and safety of dipeptidyl peptidase inhibitors versus Metformin in diabetic hypertensive patients. 🎓 She earned an M.A. in Pharmacology and Toxicology from Suez Canal University (2014), specializing in oncology and endocrinology. Dr. Zaafar also completed a Clinical Pharmacy diploma (2019-2021) in critical care and further honed her skills through a Data Analysis Professional Nano-degree (2021) and other specialized certifications in clinical pharmacology and pharmacoeconomics. 📚💻
Current Role and Focus 💼
Dr. Dalia Zaafar is an Assistant Professor at the Modern University for Technology and Information (MTI), Egypt, where she has been teaching and conducting research since 2019. 🌟 She designs experimental studies, collaborates internationally, and mentors young researchers. Additionally, she serves on the editorial boards of the Universal Journal of Pharmaceutical Research and the World Journal of Clinical Cases. 📘 Previously, she worked as a Clinical Pharmacist in critical care at Teacher’s Hospital and Abu Sower Medical Center. Dr. Zaafar has expertise in clinical pharmacy, research supervision, and interdisciplinary initiatives, fostering academic growth and innovation. 🧪👩🏫
Participation in Conferences 🌐
Dr. Dalia Zaafar was a speaker at the 18th International Conference of Biochemistry and Molecular Biology, held on September 16-17, 2023. 🌍 Her lecture, titled “Unravelling the Complexities of Tau Protein Dysfunction in Alzheimer’s Disease: Pathophysiology, Biomarkers, and Therapeutic Perspectives”, highlighted groundbreaking insights into the mechanisms of Alzheimer’s disease. 🧠🔬 She discussed emerging biomarkers and innovative therapeutic strategies, contributing to a deeper understanding of this critical neurodegenerative condition. Dr. Zaafar’s presentation underscored her expertise in molecular biology and her dedication to advancing research for a better future for humanity. 🌟
Research Focus Area 🌱🧬
Dr. Dalia Zaafar’s research is focused on pharmacology, toxicology, and clinical pharmacy, with a multidisciplinary approach to tackling critical health challenges. 🧪 Her studies emphasize drug safety, cardiovascular pharmacology, and oncology, exploring innovative therapeutic interventions for diseases like Alzheimer’s, Parkinson’s, colon cancer, and drug-induced toxicities. 🔬 Her work integrates molecular biology, nanotechnology, and experimental pharmacology, addressing mechanisms like tumor angiogenesis, neuroprotection, and signal pathway modulation. 🌍 Dr. Zaafar’s impactful contributions also span natural product-based therapies, nanoparticles for drug delivery, and biomarker development, making her a pioneer in advancing personalized medicine and enhancing treatment efficacy. 🌟
Publication Top Notes📚🌐
Role of metformin in suppressing 1, 2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation
Hesperetin mitigates sorafenib-induced cardiotoxicity in mice through inhibition of the TLR4/NLRP3 signaling pathway
Selenium nanoparticles with prodigiosin rescue hippocampal damage associated with epileptic seizures induced by pentylenetetrazole in rats
Orexin pathway in Parkinson’s disease: a review
Discovery of new 1, 3, 4-oxadiazoles with dual activity targeting the cholinergic pathway as effective anti-Alzheimer agents
Comparing the effectiveness of L-carnitine and paraffin oil in acute aluminum phosphide poisoning using predictive biomarkers and scores: a randomized controlled clinical trial
Adherence to insulin therapy among children with type 1 diabetes: reliability and validity of the Arabic Version of the 4-Item Morisky Medication Adherence Scale
Combined β-sitosterol and trimetazidine mitigate potassium dichromate-induced cardiotoxicity in rats through the interplay between NF-κB/AMPK/mTOR/TLR4 and HO-1/NADPH signaling …
Salix subserrata Bark Extract–Loaded Chitosan Nanoparticles Attenuate Neurotoxicity Induced by Sodium Arsenate in Rats in Relation with HPLC–PDA-ESI–MS …
Conclusion 🔍
Dr. Dalia Zaafar’s dedication to research excellence, her leadership in mentoring young women researchers, and her impressive body of scholarly work make her a highly suitable candidate for the Women Researcher Award. Her contributions to pharmacology, particularly in clinical studies, and her active role in global research collaborations position her as an influential figure in the academic community.